BDBM50099691 2-(2-{[1-(4-Carboxy-2-{2-[(9,10-dioxo-9,10-dihydro-phenanthrene-2-carbonyl)-amino]-5-guanidino-pentanoylamino}-butyryl)-pyrrolidine-2-carbonyl]-amino}-5-guanidino-pentanoylamino)-pentanedioic acid::CHEMBL49937

SMILES NC(=N)NCCCC(NC(=O)C1CCCN1C(=O)C(CCC(O)=O)NC(=O)C(CCCNC(N)=N)NC(=O)c1ccc2-c3ccccc3C(=O)C(=O)c2c1)C(=O)NC(CCC(O)=O)C(O)=O

InChI Key InChIKey=PEFCDHBHHURBTL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50099691   

TargetReceptor-type tyrosine-protein phosphatase C(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099691(2-(2-{[1-(4-Carboxy-2-{2-[(9,10-dioxo-9,10-dihydro...)
Affinity DataIC50: 900nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed